A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

ClinicalTrials.gov ID: NCT06010329

Public ClinicalTrials.gov record NCT06010329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-label, Phase 2 Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (Uncommon EGFR Mutations Only)

Study identification

NCT ID: NCT06010329
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Teligene US; Industry
Enrollment: 66 participants

Conditions and interventions

Conditions

Non-small Cell Lung Cancer

Interventions

Sutetinib Maleate Capsule Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 26, 2023
Primary completion: Nov 30, 2027
Completion: Nov 30, 2028
Last update posted: Apr 23, 2026

2023 – 2028

United States locations

U.S. sites: 9
U.S. states: 7
U.S. cities: 9

Facility	City	State	ZIP	Site status
Oncology Physicians Network Healthcare	Glendale	California	91203	Withdrawn
University of California San Diego Moores Cancer Center	La Jolla	California	92093	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
University Cancer & Blood Center (UCBC) - Athens	Athens	Georgia	30607	Recruiting
Mission Cancer + Blood - Mission Cancer Foundation	Des Moines	Iowa	50309	Recruiting
Norton Cancer Institute - Downtown	Louisville	Kentucky	40202	Withdrawn
Northwell Health	New Hyde Park	New York	11042	Active, not recruiting
Perlmutter Cancer Center - 34th Street	New York	New York	10016	Recruiting
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06010329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 23, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06010329 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →